Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b. Ingwersen, J., Menge, T., Wingerath, B., Kaya, D., Graf, J., Prozorovski, T., Keller, A., Backes, C., Beier, M., Scheffler, M., Dehmel, T., Kieseier, B. C., Hartung, H. P., Kury, P., & Aktas, O. Ann. Clin. Transl. Neurol., 2(1):43–55, Jan, 2015.
bibtex   
@Article{pmid25642434,
   Author="Ingwersen, J.  and Menge, T.  and Wingerath, B.  and Kaya, D.  and Graf, J.  and Prozorovski, T.  and Keller, A.  and Backes, C.  and Beier, M.  and Scheffler, M.  and Dehmel, T.  and Kieseier, B. C.  and Hartung, H. P.  and Kury, P.  and Aktas, O. ",
   Title="{{N}atalizumab restores aberrant mi{R}{N}{A} expression profile in multiple sclerosis and reveals a critical role for mi{R}-20b}",
   Journal="Ann. Clin. Transl. Neurol.",
   Year="2015",
   Volume="2",
   Number="1",
   Pages="43--55",
   Month="Jan"
}

Downloads: 0